TY - JOUR
T1 - Factors associated with polypharmacy and the high risk of medication-related problems among older community-dwelling adults in European countries
T2 - a longitudinal study
AU - Ye, Lizhen
AU - Yang-Huang, Junwen
AU - Franse, Carmen Betsy
AU - Rukavina, Tomislav
AU - Vasiljev, Vanja
AU - Mattace-Raso, Francesco
AU - Verma, Arpana
AU - Borrás, Tamara Alhambra
AU - Rentoumis, Tasos
AU - Raat, Hein
N1 - Funding Information:
Urban Health Centres Europe is funded by the European Union, Consumers, Health, Agriculture and Food Executive Agency (CHAFEA), third health program, number 20131201.
Funding Information:
The study was approved by the Medical Ethics Committees in all participating cities and funded by the European Commission Executive Agency for Health and Consumers. The names of the review board and the approval references are: Rotterdam, The Netherlands: Medische Ethische Toetsings Commissie (METC)—Erasmus MC Rotterdam; 08/01/2015; MEC-2014–661; Pallini, Greece: The Ethics and Scientific board—Latriko Palaiou Falirou Hospital; 04/03/2015; 20150304–01; Rijeka, Croatia: The Ethical Committee—Faculty of Medicine University of Rijeka; 07–04-2014; 2170–24-01–14-02; Valencia, Spain: Comisión de Investigación—Consorcio Hospital General Universitario de Valencia. 29/01/2015; CICHGUV-2015–01-29; Manchester, United Kingdom: NRES Committee West Midlands—Coventry & Warwickshire; 06–03-2015; 15/WM/0080; NRES Committee South Central Berkshire B; 29–20-2014; 14/SC/1349. Written informed consent was obtained from all participants []. The study was registered in the ISRCTN registry as ISRCTN52788952. All methods were carried out in accordance with relevant guidelines and regulations.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/11/7
Y1 - 2022/11/7
N2 - Background: Polypharmacy can be defined as using five or more medications simultaneously. “Medication-related problems”, an extension of polypharmacy, includes inappropriate prescribing, poor adherence, overdosage, underdosage, inappropriate drug selection, inadequate monitoring, adverse drug effects, and drug interactions. Polypharmacy and the high risk of medication-related problems among older people are associated with adverse health consequences due to drug-drug interactions, drug-disease interactions, and adverse drug effects. This study aims to assess the factors associated with polypharmacy and the high risk of medication-related problems among community-dwelling older people in the Netherlands, Greece, Croatia, Spain, United Kingdom. Method: This longitudinal study used baseline and follow-up data from 1791 participants of the Urban Health Center European project. Polypharmacy and the risk of medication-related problems were evaluated at baseline and follow-up using the Medication Risk Questionnaire. We studied factors in the domains (a) sociodemographic characteristics, (b) lifestyle and nutrition, and (c) health and health care use. Hierarchical logistic regression analyses were used to examine the factors associated with polypharmacy and the high risk of medication-related problems. Results: Mean age was 79.6 years (SD ± 5.6 years); 60.8% were women; 45.2% had polypharmacy, and 41.8% had a high risk of medication-related problems. Women participants had lower odds of polypharmacy (OR = 0.55;95%CI:0.42–0.72) and a high risk of medication-related problems (OR = 0.50; 95%CI:0.39–0.65). Participants with a migration background (OR = 1.67;95%CI:1.08–2.59), overweight (OR = 1.37; 95%CI:1.04–1.79) and obesity (OR = 1.78;95%CI:1.26–2.51) compared to ‘normal weight’, with lower physical HRQoL (OR = 0.96, 95%CI:0.95–0.98), multi-morbidity (OR = 3.73, 95%CI:2.18–6.37), frailty (OR = 1.69, 95%CI:1.24–2.30), visited outpatient services (OR = 1.77, 95%CI: 1.09–2.88) had higher odds of polypharmacy. The associations with the high risk of medication-related problems were similar. Conclusions: Multiple factors in demography, lifestyle, nutrition, and health care use are associated with polypharmacy and the high risk of medication-related problems. Polypharmacy is a single element that may reflect the number of medications taken. The broader content of medication-related problems should be considered to assess the context of medication use among older people comprehensively. These provide starting points to improve interventions to reduce polypharmacy and high risk of medication-related problems. In the meantime, health professionals can apply these insights to identify subgroups of patients at a high risk of polypharmacy and medication-related problems. Trial registration: The intervention of the UHCE project was registered in the ISRCTN registry as ISRCTN52788952. The date of registration is 13/03/2017.
AB - Background: Polypharmacy can be defined as using five or more medications simultaneously. “Medication-related problems”, an extension of polypharmacy, includes inappropriate prescribing, poor adherence, overdosage, underdosage, inappropriate drug selection, inadequate monitoring, adverse drug effects, and drug interactions. Polypharmacy and the high risk of medication-related problems among older people are associated with adverse health consequences due to drug-drug interactions, drug-disease interactions, and adverse drug effects. This study aims to assess the factors associated with polypharmacy and the high risk of medication-related problems among community-dwelling older people in the Netherlands, Greece, Croatia, Spain, United Kingdom. Method: This longitudinal study used baseline and follow-up data from 1791 participants of the Urban Health Center European project. Polypharmacy and the risk of medication-related problems were evaluated at baseline and follow-up using the Medication Risk Questionnaire. We studied factors in the domains (a) sociodemographic characteristics, (b) lifestyle and nutrition, and (c) health and health care use. Hierarchical logistic regression analyses were used to examine the factors associated with polypharmacy and the high risk of medication-related problems. Results: Mean age was 79.6 years (SD ± 5.6 years); 60.8% were women; 45.2% had polypharmacy, and 41.8% had a high risk of medication-related problems. Women participants had lower odds of polypharmacy (OR = 0.55;95%CI:0.42–0.72) and a high risk of medication-related problems (OR = 0.50; 95%CI:0.39–0.65). Participants with a migration background (OR = 1.67;95%CI:1.08–2.59), overweight (OR = 1.37; 95%CI:1.04–1.79) and obesity (OR = 1.78;95%CI:1.26–2.51) compared to ‘normal weight’, with lower physical HRQoL (OR = 0.96, 95%CI:0.95–0.98), multi-morbidity (OR = 3.73, 95%CI:2.18–6.37), frailty (OR = 1.69, 95%CI:1.24–2.30), visited outpatient services (OR = 1.77, 95%CI: 1.09–2.88) had higher odds of polypharmacy. The associations with the high risk of medication-related problems were similar. Conclusions: Multiple factors in demography, lifestyle, nutrition, and health care use are associated with polypharmacy and the high risk of medication-related problems. Polypharmacy is a single element that may reflect the number of medications taken. The broader content of medication-related problems should be considered to assess the context of medication use among older people comprehensively. These provide starting points to improve interventions to reduce polypharmacy and high risk of medication-related problems. In the meantime, health professionals can apply these insights to identify subgroups of patients at a high risk of polypharmacy and medication-related problems. Trial registration: The intervention of the UHCE project was registered in the ISRCTN registry as ISRCTN52788952. The date of registration is 13/03/2017.
KW - Polypharmacy; Medication-related problems; Older people; Sex; Migration background, BMI, frailty, outpatient services, Health related quality of life
KW - Polypharmacy
KW - Drug-Related Side Effects and Adverse Reactions/epidemiology
KW - Europe/epidemiology
KW - Inappropriate Prescribing
KW - Humans
KW - Independent Living
KW - Female
KW - Male
KW - Aged
KW - Longitudinal Studies
UR - http://www.scopus.com/inward/record.url?scp=85141355627&partnerID=8YFLogxK
U2 - 10.1186/s12877-022-03536-z
DO - 10.1186/s12877-022-03536-z
M3 - Article
C2 - 36344918
AN - SCOPUS:85141355627
SN - 1471-2318
VL - 22
JO - BMC Geriatrics
JF - BMC Geriatrics
IS - 1
M1 - 841
ER -